None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: •Male and female subjects aged 18 to 60 years (both the ages inclusive) •Ready to provide written informed consent •No history of any known allergy with Chyawanprash like products or any of the ingredientts of the Ratnaprash •Willing to come for the follow up visits for evaluation
Exclusion criteria
Exclusion criteria: •Presence of clinically significant abnormal laboratory, ECG or X-ray findings during screening. •Patients with known uncontrolled diabetes mellitus (DM), hypertension (HT), symptomatic congestive heart failure (CHF), unstable angina pectoris, myocardial infarction (MI) •Patients participated in another clinical drug trial within 3 months before recruitment in this trial •Any other medical condition that in the Investigators opinion would preclude patient participation •Pregnant and breast feeding women and women of child bearing age refusing to use contraceptive measures •Immunologically compromised individuals
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessment of quality of life (QoL) and number of episodes, severity and duration of illness during the study periodTimepoint: 90 days (3 months) | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess level of Energy and overall health status, physical fitness, level of endurance or stamina and physical strength, level of stress, Physicianâ??s Global evaluation, Laboratory parameters for safety and immunity and PalatabilityTimepoint: 90 days (3 months) | — |
Countries
India
Contacts
Dabur India Limited